Accuray Incorporated (NASDAQ:ARAY) Shares Sold by Silverback Asset Management LLC

Silverback Asset Management LLC lessened its stake in shares of Accuray Incorporated (NASDAQ:ARAY - Free Report) by 99.5% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 69,061 shares of the medical equipment provider's stock after selling 15,026,939 shares during the period. Silverback Asset Management LLC owned about 0.07% of Accuray worth $137,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of ARAY. Prudential Financial Inc. purchased a new stake in shares of Accuray in the 4th quarter worth approximately $43,000. SG Americas Securities LLC lifted its holdings in Accuray by 37.4% during the fourth quarter. SG Americas Securities LLC now owns 45,079 shares of the medical equipment provider's stock worth $89,000 after buying an additional 12,259 shares during the period. Intech Investment Management LLC increased its holdings in shares of Accuray by 104.1% in the 4th quarter. Intech Investment Management LLC now owns 46,680 shares of the medical equipment provider's stock valued at $92,000 after acquiring an additional 23,808 shares during the period. Perkins Capital Management Inc. raised its position in shares of Accuray by 18.3% in the 4th quarter. Perkins Capital Management Inc. now owns 68,000 shares of the medical equipment provider's stock worth $135,000 after acquiring an additional 10,500 shares in the last quarter. Finally, Virtu Financial LLC bought a new position in Accuray in the third quarter worth about $244,000. Institutional investors own 64.08% of the company's stock.

Analysts Set New Price Targets

Separately, StockNews.com raised Accuray from a "hold" rating to a "buy" rating in a research report on Friday, April 11th.

Accuray Stock Up 1.4 %

NASDAQ ARAY traded up $0.02 during trading on Friday, hitting $1.48. The company's stock had a trading volume of 549,944 shares, compared to its average volume of 729,499. Accuray Incorporated has a fifty-two week low of $1.40 and a fifty-two week high of $2.95. The company has a debt-to-equity ratio of 3.51, a current ratio of 1.62 and a quick ratio of 0.88. The company has a market cap of $152.19 million, a PE ratio of -29.60 and a beta of 1.30. The business's 50 day simple moving average is $1.85 and its 200-day simple moving average is $1.95.

Accuray (NASDAQ:ARAY - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $0.02 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.01) by $0.03. Accuray had a negative net margin of 0.96% and a negative return on equity of 9.75%. On average, equities analysts anticipate that Accuray Incorporated will post 0.01 EPS for the current fiscal year.

Accuray Company Profile

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate.